XIEON, established in 2007, was founded with the core mission of manufacturing, marketing, and promoting pharmaceutical specialties. Our aim is to ensure that high-quality medicines reach even the most remote and interior regions. Over the past year, XIEON has made remarkable progress, positioning itself as a leading pharmaceutical company in healthcare.
In the pharmaceutical industry, consumer protection holds paramount importance as customers often cannot independently verify the safety and efficacy of the drugs they purchase. To uphold product quality, XIEON operates under a stringent Quality Management System, as detailed in our Quality System Manual. This ensures compliance with legal requirements and standards jointly set by our customers and our internal benchmarks.
Today, we proudly operate over 1,20,000 square meters of manufacturing space. All our facilities are ISO 9001:2015, WHO-GMP, and c-GMP certified. XIEON has successfully expanded into nutraceuticals, cosmetics, injectables, medicines, and herbal preparations. In addition to serving the domestic market through renowned divisions and contract manufacturing, we have also established a strong presence internationally, exporting to over 15 countries. By 2015, we had achieved a benchmark turnover of $20 million.
Our vision for the future is to expand our reach to more countries, offering an even wider range of high-quality products.